abstract |
(57) [Summary]nThe disclosed invention is based on the observation that a functional NMDA receptor is present on osteoclasts. The use of NMDA antagonists to inhibit bone resorption is disclosed and is therefore useful in treating bone diseases such as osteoporosis and Paget's disease. The NMDA antagonists used are phencyclidine and dizocilpine. |